Global Ambulatory Infusion Pump Market Size By Type (Mechanics Pump, Electronic Pump), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Ambulatory Infusion Pump Market was valued at USD 5.6 billion in 2023 and is projected to surpass USD 9.4 billion by 2031, expanding at a CAGR of 6.6% during the forecast period from 2023 to 2031. Growth in the market is driven by the rising prevalence of chronic diseases, an aging global population, and increasing demand for home-based healthcare solutions. Ambulatory infusion pumps offer a convenient and cost-effective method for continuous drug delivery outside hospital settings, supporting better patient compliance and healthcare outcomes.

Drivers:

1. Increasing Incidence of Chronic Diseases:

The rising prevalence of chronic illnesses such as diabetes, cancer, and autoimmune disorders has necessitated long-term infusion therapies, propelling the demand for portable and efficient infusion delivery systems.

2. Shift Toward Home Healthcare:

There is a growing trend of shifting patient care from hospitals to home settings to reduce healthcare costs and improve quality of life. Ambulatory infusion pumps are crucial in this transition, offering flexibility and reducing hospital readmissions.

3. Advancements in Pump Technology:

Continuous innovation in pump design, software integration, and connectivity features is enhancing device safety, usability, and patient adherence, further supporting market growth.

Restraints:

1. High Device and Maintenance Costs:

The initial acquisition and regular maintenance of advanced ambulatory infusion systems can be costly, especially for small-scale healthcare providers or patients in low-income regions.

2. Regulatory and Compliance Challenges:

Strict regulatory frameworks concerning device safety, efficacy, and data protection can slow down product approvals and market entry, particularly for emerging players.

Opportunity:

1. Expansion in Emerging Economies:

The expansion of healthcare infrastructure in developing regions such as Asia-Pacific and Latin America presents substantial growth opportunities, supported by increasing healthcare expenditure and rising awareness.

2. Integration with Digital Health Platforms:

Combining infusion pumps with telemedicine and remote patient monitoring technologies offers an untapped avenue for enhancing real-time therapy tracking and improving treatment outcomes.

Market by System Type Insights:

The market is segmented by system type into volumetric infusion pumps, syringe infusion pumps, and elastomeric pumps. In 2023, the volumetric infusion pump segment led the market due to its precision and widespread use in chemotherapy, pain management, and parenteral nutrition. However, the syringe pump segment is expected to grow significantly owing to its compact size and suitability for pediatric and neonatal care.

Market by End-use Insights:

By end-use, home care settings accounted for the largest market share in 2023, attributed to the increasing preference for home-based care among patients requiring long-term infusion therapy. The ambulatory surgical centers (ASCs) segment is projected to witness notable growth as outpatient procedures rise in volume due to cost-efficiency and faster patient turnaround.

Market by Regional Insights:

North America dominated the global market in 2023, supported by robust healthcare infrastructure, strong reimbursement frameworks, and the early adoption of advanced medical technologies. Asia-Pacific is expected to register the fastest growth through 2031, driven by rising healthcare awareness, expanding insurance coverage, and the development of medical device manufacturing hubs in countries like China and India.

Competitive Scenario:

Key players in the Global Ambulatory Infusion Pump Market include:

Baxter International Inc.

B. Braun Melsungen AG

Smiths Medical

ICU Medical, Inc.

Fresenius Kabi

Terumo Corporation

Moog Inc.

Zyno Medical

Nipro Corporation

Micrel Medical Devices

These companies are focusing on technological innovation, geographic expansion, and strategic collaborations to strengthen their market position. For example:

In 2023, Baxter launched a next-generation ambulatory infusion system integrated with wireless connectivity for real-time monitoring.

Smiths Medical introduced an advanced pain management pump in 2024, tailored for home-based palliative care.

ICU Medical expanded its infusion therapy portfolio through the acquisition of a specialized pump manufacturer in early 2025.

Scope of Work – Global Ambulatory Infusion Pump Market

Report Metric Details

Market Size (2023) USD 5.6 Billion

Projected Market Size (2031) USD 9.4 Billion

CAGR (2023-2031) 6.6%

Market Segments System Type, End-Use, Region

Growth Drivers Chronic disease prevalence, home care demand, tech innovation

Opportunities Emerging markets, digital health integration

Key Market Developments:

April 2023: Terumo Corporation announced a new ambulatory syringe pump with enhanced safety features for oncology applications.

September 2024: Fresenius Kabi unveiled a mobile health-integrated pump for at-home antibiotic therapy.

January 2025: Moog Inc. partnered with a digital therapeutics platform to co-develop connected infusion solutions for post-surgical recovery.

FAQs:

1) What is the current market size of the Global Ambulatory Infusion Pump Market?

The market size was USD 5.6 billion in 2023.

2) What is the major growth driver of the Global Ambulatory Infusion Pump Market?

The primary growth driver is the increasing prevalence of chronic diseases and the rise in demand for home-based healthcare solutions.

3) Which is the largest region during the forecast period in the Global Ambulatory Infusion Pump Market?

North America remains the largest region due to its advanced healthcare infrastructure and early adoption of medical technologies.

4) Which segment accounted for the largest market share in the Global Ambulatory Infusion Pump Market?

The volumetric infusion pump segment accounted for the largest share in 2023.